NDC product
Piperacillin and Tazobactam and Sodium Chloride
NDC 0264-3450 · B. Braun Medical Inc.
Key facts
| Product NDC | 0264-3450 |
|---|---|
| Proprietary name | Piperacillin and Tazobactam and Sodium Chloride |
| Nonproprietary name | Piperacillin and Tazobactam and Sodium Chloride |
| Substances | TAZOBACTAM SODIUM, PIPERACILLIN SODIUM |
| Dosage form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Labeler | B. Braun Medical Inc. |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Application number | NDA206056 |
| Pharmacologic classes | Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA] |
| Marketing start | Sep 30, 2025 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: